Psychedelika in der Psychiatrie - Entwicklungen und die Stellung in Deutschland

Translated title of the contribution: Psychedelics in Psychiatry - Development and Current State in Germany

Uwe Herwig*, Lea Mertens, Sergio Pérez Rosal, Gabriele Koller, Andrea Jungaberle, Stefan Borgwardt, Gerhard Gründer

*Corresponding author for this work


Clinical research on the therapeutic efficacy of psychedelics is currently experiencing a renaissance. Available scientific evidence on their efficacy in various psychiatric conditions, as well as their legally approved use in some countries of the world, show the possibility of their future application in clinical practice also in Germany. The field is facing substantial challenges that have to be addressed, such as defining and setting a suitable clinical frame. This manuscript deals with the historical background of the clinical application of psychedelics, as well as the psycho-phenomenology, modes of action, possible indications and aspects of safety. The current research status in Germany and the organization of professional societies are discussed in a historical and international context and attention is drawn to unresolved critical issues in the field.

Translated title of the contributionPsychedelics in Psychiatry - Development and Current State in Germany
Original languageGerman
JournalFortschritte der Neurologie Psychiatrie
Issue number7-8
Pages (from-to)311-318
Number of pages8
Publication statusPublished - 04.07.2022

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

DFG Research Classification Scheme

  • 206-10 Clinical Psychiatry, Psychotherapy amd Paediatric and Juvenile Psychiatrie
  • 205-08 Pharmaceutics

Cite this